1. Hippisley-Cox J, Coupland C. Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney®Scores. BMC Fam Pract. 2010;11:49.
2. Gilg J, Methven S, Casula A, Castledine C. UK renal registry 19th annual report: chapter 1 UK RRT adult incidence in 2015: national and centre-specific analyses. Nephron. 2017;137(Suppl 1):11–44.
3. Combe H, Vol S, Thévenot A, Lasfargues G, Cacès E, Tichet J, et al. Comparison of men with impaired fasting glycaemia to controls and to diabetic subjects with fasting glycaemia from 7.0 to 7.7 mmol/l: clinical, nutritional and biological status. Diabetes Metab. 2004;30(2):167–74.
4. Steenkamp R, Pyart R, Fraser S. Chapter 5 survival and cause of death in UK adult patients on renal replacement therapy in 2016. Nephron. 2018;139(Suppl 1):117–50.
5. Nitsch D, Burden R, Steenkamp R, Ansell D, Byrne C, Caskey F, et al. Patients with diabetic nephropathy on renal replacement therapy in England and Wales. QJM. 2007;100(9):551–60.